{"id":"https://openalex.org/W2289340676","doi":"https://doi.org/10.1158/1535-7163.targ-15-c190","title":"Abstract C190: Potent and selective inhibition of CDK7 by novel covalent inhibitors","display_name":"Abstract C190: Potent and selective inhibition of CDK7 by novel covalent inhibitors","publication_year":2015,"publication_date":"2015-12-01","ids":{"openalex":"https://openalex.org/W2289340676","doi":"https://doi.org/10.1158/1535-7163.targ-15-c190","mag":"2289340676"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-15-c190","doi":"https://doi.org/10.1158/1535-7163.targ-15-c190","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-15-c190","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2289340676"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084429791","display_name":"Ramulu Poddutoori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ramulu Poddutoori","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049473019","display_name":"Leena Khare Satyam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Leena K. Satyam","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074867808","display_name":"Girish Daginakatte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Girish Daginakatte","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066740338","display_name":"Subhendu Mukherjee","orcid":"https://orcid.org/0000-0002-4851-4428","observed_orcids":["https://orcid.org/0000-0002-4851-4428"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Subhendu Mukherjee","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050147564","display_name":"Sivapriya Marappan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sivapriya Marappan","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049675874","display_name":"Sreevalsam Gopinath","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sreevalsam Gopinath","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085141768","display_name":"Raghuveer K. Ramachandra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Raghuveer Ramachandra","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076581588","display_name":"Anirudha Lakshminarasimhan","orcid":"https://orcid.org/0000-0002-3008-0350","observed_orcids":["https://orcid.org/0000-0002-3008-0350"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Anirudha Lakshminarasimhan","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063015219","display_name":"Manoj Kumar Pothuganti","orcid":"https://orcid.org/0000-0002-2617-0011","observed_orcids":["https://orcid.org/0000-0002-2617-0011"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Manoj Pothuganti","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020172528","display_name":"Shilpa S. Nayak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shilpa Nayak","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060354571","display_name":"C Nandish","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Nandish C","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036670008","display_name":"Chandranath D. Naik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Chandranath Naik","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084224654","display_name":"Ravindra MV","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ravindra MV","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040461835","display_name":"Dabbeeru Madhu Babu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Madhu Dabbeeru","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102728666","display_name":"Thomas Antony","orcid":"https://orcid.org/0000-0002-0739-5776","observed_orcids":["https://orcid.org/0000-0002-0739-5776"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Thomas Antony","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009141925","display_name":"Chetan Pandit","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Chetan Pandit","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065784113","display_name":"Murali Ramachandra","orcid":"https://orcid.org/0000-0003-4039-1491","observed_orcids":["https://orcid.org/0000-0003-4039-1491"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Murali Ramachandra","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024438197","display_name":"Shekar Chelur","orcid":"https://orcid.org/0000-0001-7017-4063","observed_orcids":["https://orcid.org/0000-0001-7017-4063"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shekar Chelur","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039885523","display_name":"Susanta Samajdar","orcid":"https://orcid.org/0000-0002-3508-4801","observed_orcids":["https://orcid.org/0000-0002-3508-4801"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Susanta Samajdar","raw_affiliation_strings":["Aurigene Discovery Technologies Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210152788"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"12_Supplement_2","first_page":"C190","last_page":"C190"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.7411999702453613,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.7411999702453613,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.053599998354911804,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.02710000053048134,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk7-inhibitor","display_name":"CDK7 inhibitor","score":0.902999997138977},{"id":"https://openalex.org/keywords/covalent-kinase-inhibitors","display_name":"covalent kinase inhibitors","score":0.8830000162124634},{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-7","display_name":"cyclin-dependent kinase 7","score":0.9259999990463257},{"id":"https://openalex.org/keywords/rna-polymerase-ii-c-terminal-domain-phosphorylation","display_name":"RNA polymerase II C-terminal domain phosphorylation","score":0.9150000214576721},{"id":"https://openalex.org/keywords/transcriptional-regulation","display_name":"transcriptional regulation","score":0.597000002861023},{"id":"https://openalex.org/keywords/anticancer-drug-discovery","display_name":"anticancer drug discovery","score":0.722000002861023},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.7269999980926514},{"id":"https://openalex.org/keywords/time-dependent-inhibition","display_name":"time-dependent inhibition","score":0.7400000095367432},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8610000014305115},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7549999952316284},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.6930000185966492},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7289999723434448},{"id":"https://openalex.org/keywords/medicinal-chemistry-optimization","display_name":"medicinal chemistry optimization","score":0.6610000133514404},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C94734110","wikidata":"https://www.wikidata.org/wiki/Q18021240","display_name":"Cyclin-dependent kinase 7","level":5,"score":0.8892909288406372},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5934231281280518},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5903267860412598},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.47544217109680176},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.4702628552913666},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.45122188329696655},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42131394147872925},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2698521614074707},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2613305449485779},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.15313231945037842},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.07849255204200745}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-15-c190","doi":"https://doi.org/10.1158/1535-7163.targ-15-c190","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-15-c190","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2485998015","https://openalex.org/W2785799318","https://openalex.org/W2740107527","https://openalex.org/W2787667264","https://openalex.org/W2969912396","https://openalex.org/W4256647402","https://openalex.org/W4379984345","https://openalex.org/W1979173936","https://openalex.org/W3023627784","https://openalex.org/W3083070789"],"abstract_inverted_index":{"Abstract":[0],"Cyclin-dependent":[1],"kinase":[2,45],"7":[3],"(CDK7)":[4],"is":[5,47],"an":[6,50],"important":[7],"constituent":[8],"of":[9,21,37,43,57,116,121,169,274,283],"the":[10,17,284],"cellular":[11],"transcriptional":[12],"machinery,":[13],"where":[14],"it":[15],"phosphorylates":[16],"C-terminal":[18],"domain":[19],"(CTD)":[20],"RNAP":[22],"polymerase":[23],"II":[24],"(RNAPII).":[25],"Because":[26],"many":[27],"tumor":[28,135,197],"types":[29,136],"are":[30,102,186,220],"critically":[31],"dependent":[32],"on":[33,196],"transcription":[34],"for":[35,223],"maintenance":[36],"their":[38,194],"oncogenic":[39],"state,":[40],"pharmacological":[41],"modulation":[42,143],"CDK7":[44,58,107,117,142,209,275],"activity":[46,128,225],"considered":[48],"as":[49,146],"approach":[51],"to":[52,88,192],"treat":[53],"cancer.":[54],"Multiple":[55],"series":[56,100,177,214],"inhibitors":[59,112,211],"were":[60,73],"identified":[61,94,205],"by":[62,141,148,276],"iterative":[63],"medicinal":[64],"chemistry":[65],"efforts":[66],"and":[67,84,137,161,183,207,271,290],"SAR":[68],"based":[69],"approach.":[70],"Early":[71],"compounds":[72,95,124,174],"optimized":[74],"towards":[75],"attaining":[76],"good":[77,82,162,179],"physicochemical":[78],"properties,":[79,218],"high":[80],"potency,":[81],"selectivity":[83,180],"desirable":[85,216],"pharmacokinetic":[86],"profile":[87],"achieve":[89],"anti-tumor":[90,224],"activity.":[91],"We":[92,203],"have":[93,152,204],"from":[96,133,175,212],"two":[97,213],"distinct":[98],"chemical":[99],"that":[101],"highly":[103],"potent":[104,126],"in":[105,108,129,144,200,226],"inhibiting":[106],"biochemical":[109],"assays.":[110],"These":[111],"demonstrate":[113],"time-dependent":[114],"inhibition":[115,199,273],"indicating":[118],"covalent":[119,210,278],"nature":[120],"binding.":[122],"The":[123],"showed":[125,178],"anti-proliferative":[127],"cell":[130],"lines":[131],"derived":[132],"various":[134],"this":[138],"was":[139],"accompanied":[140],"cells":[145],"monitored":[147],"pS5RNAPII":[149],"levels.":[150],"They":[151],"excellent":[153],"drug-like":[154,217],"characteristics":[155],"including":[156],"solubility,":[157],"permeability,":[158],"metabolic":[159],"stability":[160],"oral":[163],"bioavailability.":[164],"In":[165],"a":[166],"broad":[167],"panel":[168],"kinases":[170],"(332":[171],"kinase),":[172],"selected":[173,189],"both":[176],"profile.":[181],"Tolerability":[182],"efficacy":[184],"studies":[185],"ongoing":[187],"with":[188,215],"early":[190],"leads":[191],"test":[193],"impact":[195],"growth":[198],"xenograft":[201,227],"models.":[202,228],"novel":[206,277],"selective":[208,272],"which":[219],"being":[221],"evauated":[222],"Citation":[229],"Format:":[230],"Ramulu":[231],"Poddutoori,":[232],"Leena":[233],"K.":[234],"Satyam,":[235],"Girish":[236],"Daginakatte,":[237],"Subhendu":[238],"Mukherjee,":[239],"Sivapriya":[240],"Marappan,":[241],"Sreevalsam":[242],"Gopinath,":[243],"Raghuveer":[244],"Ramachandra,":[245,265],"Anirudha":[246],"Lakshminarasimhan,":[247],"Manoj":[248],"Pothuganti,":[249],"Shilpa":[250],"Nayak,":[251],"Nandish":[252],"C,":[253],"Chandranath":[254],"Naik,":[255],"Ravindra":[256],"MV,":[257],"Madhu":[258],"Dabbeeru,":[259],"Thomas":[260],"Antony,":[261],"Chetan":[262],"Pandit,":[263],"Murali":[264],"Shekar":[266],"Chelur,":[267],"Susanta":[268],"Samajdar.":[269],"Potent":[270],"inhibitors.":[279],"[abstract].":[280],"In:":[281],"Proceedings":[282],"AACR-NCI-EORTC":[285],"International":[286],"Conference:":[287],"Molecular":[288],"Targets":[289],"Cancer":[291,302],"Therapeutics;":[292],"2015":[293],"Nov":[294],"5-9;":[295],"Boston,":[296],"MA.":[297],"Philadelphia":[298],"(PA):":[299],"AACR;":[300],"Mol":[301],"Ther":[303],"2015;14(12":[304],"Suppl":[305],"2):Abstract":[306],"nr":[307],"C190.":[308]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
